BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu DJ, Shi WJ, Yu M, Zhang L. High WDR34 mRNA expression as a potential prognostic biomarker in patients with breast cancer as determined by integrated bioinformatics analysis. Oncol Lett 2019;18:3177-87. [PMID: 31452794 DOI: 10.3892/ol.2019.10634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Wu Y, Zhang Y, Bu D, Wu C, Lu S, Huang Z, Song Y, Zhao Y, Guo F, Ye P, Fu C, Shen L, Zhang J, Wang H, Duan X, Wu J. High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer. Front Oncol 2021;11:747300. [PMID: 34604090 DOI: 10.3389/fonc.2021.747300] [Reference Citation Analysis]
2 Hao XY, Li AQ, Shi H, Guo TK, Shen YF, Deng Y, Wang LT, Wang T, Cai H. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20203945. [PMID: 33634306 DOI: 10.1042/BSR20203945] [Reference Citation Analysis]
3 Zuo J, Liu C, Ni H, Yu Z. WDR34 affects PI3K/Akt and Wnt/β-catenin pathways to regulates malignant biological behaviors of glioma cells. J Neurooncol 2022. [PMID: 34981299 DOI: 10.1007/s11060-021-03932-2] [Reference Citation Analysis]